Literature DB >> 29948444

Effect of essential amino acid кetoanalogues and protein restriction diet on morphogenetic proteins (FGF-23 and Кlotho) in 3b-4 stages chronic кidney disease patients: a randomized pilot study.

Lyudmila Milovanova1,2, Victor Fomin3,4, Sergey Moiseev3,5, Marina Taranova3,5, Yury Milovanov3,5, Lidia Lysenko Kozlovskaya3,5, Vasiliy Kozlov3,6, Elena Kozevnikova3,5, Svetlana Milovanova3,5, Marina Lebedeva3,5, Vladimir Reshetnikov3,6.   

Abstract

BACKGROUND: A low protein diet (LPD) with essential amino acid ketoanalogue supplementation (KA) may contribute in improving of chronic kidney disease (CKD), while the exact mechanisms of KA's effect are not established yet. We have conducted a prospective, randomized, controlled comparative study of LPD + KA and LPD alone in relation to serum Klotho, FGF-23 levels in CKD patients.
METHODS: 79 non-diabetic CKD 3b-4 stage patients, compliant with LPD diet (0.6 g/kg of body weight/day), had been selected. The patients were randomized into two groups. The first group (42 patients) received LPD + КA. The second group (37 patients) continued the LРD alone. In addition to routine tests, serum Klotho, FGF-23 levels, as well as bioimpedance analysis, sphygmography (stiffness (augmentation) indices (AI), central (aortal) blood pressure) with a «SphygmaCor» device; echocardiography (valvular calcification score (VCS) and LVMMI), were performed.
RESULTS: There were body mass indices' decrease (p = 0.046), including muscle body mass in men (p = 0.027) and woman (p = 0.044) in the LPD group to the end of study (14th month). In addition, lower FGF-23 (p = 0.029), and higher sKlotho (p = 0.037) were detected in the LPD + KA group compared to the LPD one. The increase in AI (p = 0.034), VCS (p = 0.048), and LVMMI (p = 0.023) was detected more often in the LPD group at the end of study.
CONCLUSION: LPD + KA provides support for nutrition status and contributes to more efficient correction of FGF-23 and Klotho abnormalities that may result in cardiovascular calcification and cardiac remodeling decreasing in CKD. At the same time, a prolonged LPD alone may lead to malnutrition.

Entities:  

Keywords:  Cardiac remodeling; Cardiovascular calcification; Chronic kidney disease; Essential amino acid ketoanalogues; Fibroblast growth factor-23 (FGF-23); Serum alpha-Klotho (sKlotho)

Mesh:

Substances:

Year:  2018        PMID: 29948444     DOI: 10.1007/s10157-018-1591-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  33 in total

Review 1.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

2.  Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.

Authors:  Sarah Seiler; Kyrill S Rogacev; Heinz J Roth; Pagah Shafein; Insa Emrich; Stefan Neuhaus; Jürgen Floege; Danilo Fliser; Gunnar H Heine
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 8.237

3.  Ketoanalogue-Supplemented Vegetarian Very Low-Protein Diet and CKD Progression.

Authors:  Liliana Garneata; Alexandra Stancu; Diana Dragomir; Gabriel Stefan; Gabriel Mircescu
Journal:  J Am Soc Nephrol       Date:  2016-01-28       Impact factor: 10.121

Review 4.  Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease.

Authors:  Xiang Lu; Ming Chang Hu
Journal:  Kidney Dis (Basel)       Date:  2016-11-17

Review 5.  Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword.

Authors:  Dong Zhou; Roderick J Tan; Haiyan Fu; Youhua Liu
Journal:  Lab Invest       Date:  2015-12-21       Impact factor: 5.662

Review 6.  The Effect of Diet on the Survival of Patients with Chronic Kidney Disease.

Authors:  Jacek Rysz; Beata Franczyk; Aleksandra Ciałkowska-Rysz; Anna Gluba-Brzózka
Journal:  Nutrients       Date:  2017-05-13       Impact factor: 5.717

7.  Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials.

Authors:  Connie M Rhee; Seyed-Foad Ahmadi; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-11-02       Impact factor: 12.910

8.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

9.  The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection.

Authors:  Ming-Chang Hu; Mingjun Shi; Han J Cho; Jianning Zhang; Alevtina Pavlenco; Shuzhen Liu; Sachdev Sidhu; Lily J-S Huang; Orson W Moe
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

10.  The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers.

Authors:  Mohamed M Nasrallah; Amal R El-Shehaby; Noha A Osman; Tarek Fayad; Amr Nassef; Mona M Salem; Usama A A Sharaf El Din
Journal:  Nephron Extra       Date:  2013-11-06
View more
  11 in total

Review 1.  Pathophysiological mechanisms leading to muscle loss in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch; S Russ Price
Journal:  Nat Rev Nephrol       Date:  2021-11-08       Impact factor: 42.439

Review 2.  Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.

Authors:  Elizabeth R Stremke; Annabel Biruete; Kathleen M Hill Gallant
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

Review 3.  Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives.

Authors:  Laetitia Koppe; Mariana Cassani de Oliveira; Denis Fouque
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

Review 4.  Role of Uremic Toxins in Early Vascular Ageing and Calcification.

Authors:  Nikolaos C Kyriakidis; Gabriela Cobo; Lu Dai; Bengt Lindholm; Peter Stenvinkel
Journal:  Toxins (Basel)       Date:  2021-01-03       Impact factor: 4.546

5.  Effects of Low Protein Diet on Modulating Gut Microbiota in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of International Studies.

Authors:  Cheng-Kai Hsu; Shih-Chi Su; Lun-Ching Chang; Shih-Chieh Shao; Kai-Jie Yang; Chun-Yu Chen; Yih-Ting Chen; I-Wen Wu
Journal:  Int J Med Sci       Date:  2021-10-25       Impact factor: 3.738

6.  Low protein diets for non-diabetic adults with chronic kidney disease.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Denis Fouque
Journal:  Cochrane Database Syst Rev       Date:  2020-10-29

7.  Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction.

Authors:  I-Wen Wu; Chin-Chan Lee; Heng-Jung Hsu; Chiao-Yin Sun; Yuen-Chan Chen; Kai-Jie Yang; Chi-Wei Yang; Wen-Hun Chung; Hsin-Chih Lai; Lun-Ching Chang; Shih-Chi Su
Journal:  Nutrients       Date:  2020-09-12       Impact factor: 5.717

8.  Anti-inflammatory and antioxidant activity of essential amino acid α-ketoacid analogues against renal ischemia-reperfusion damage in Wistar rats.

Authors:  Concepción Sánchez-Martínez; Liliana Torres-González; Gabriela Alarcón-Galván; Linda E Muñoz-Espinosa; Homero Zapata-Chavira; Diana Patricia Moreno-Peña; Homero Náñez-Terreros; Edelmiro Pérez-Rodríguez; Lourdes Garza-Ocañas; Francisco Javier Guzmán-de la Garza; Paula Andrea Cordero
Journal:  Biomedica       Date:  2020-06-15       Impact factor: 0.935

Review 9.  Klotho, Aging, and the Failing Kidney.

Authors:  Sarah Buchanan; Emilie Combet; Peter Stenvinkel; Paul G Shiels
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-27       Impact factor: 5.555

Review 10.  The Influence of Dietary Interventions on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors:  Jacek Rysz; Beata Franczyk; Robert Rokicki; Anna Gluba-Brzózka
Journal:  Nutrients       Date:  2021-06-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.